Search This Blog

Tuesday, September 17, 2013

Diabetes Alliance to Feature 17 Presentations for Linagliptin and Investigational Compound Empagliflozin^ During the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) (NYSE:LLY)

Diabetes Alliance to Feature 17 Presentations for Linagliptin and Investigational Compound Empagliflozin^ During the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.